Literature DB >> 9856097

Dissecting the mode of action of various HIV-inhibitor classes in a stable cellular system.

T Klimkait1, F Stauffer, E Lupo, C Sonderegger-Rubli.   

Abstract

We describe a stable and sensitive HIV evaluation system, which discriminates HIV-specific membrane fusion and early transcription events and is suitable for high-throughput inhibitor screening. A human lymphocytic line, constitutively producing infectious HIV-1, serves as Env-positive donor. A second indicator cell line carries a silent HIV-1 LTR lacZ reporter plasmid. A bicellular cocultivation setup allows titration and standardization of "fusion-induced gene stimulation (FIGS)" events. With few manipulations aspects of fusion and/or LTR induction can be distinguished and simultaneously assayed. Anti-Env-V3 antibodies prevent fusion and subsequent lacZ induction, and a Tat-specific inhibitor blocks only lacZ induction in a dose dependent manner without affecting membrane fusion. The LTR reporter is readily activated by Tat from HIV-1, HIV-2, or SIV and it responds to exogenous Tat protein. The reporter system is sensitive enough to detect single infection events on pre-seeded layers of indicator cells, which renders it potentially useful for direct virus quantification in patients' material. Moreover, our system allows to control and normalize DNA transfection efficiencies of HIV-derived plasmids. This aspect is particularly valuable for studies of RT- and protease-inhibitors and resistances, where p24 or supernatant reverse transcriptase, otherwise standard virus readouts, can be directly affected by inhibitors or mutations.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9856097     DOI: 10.1007/s007050050447

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  4 in total

1.  Rearranged JC virus noncoding control regions found in progressive multifocal leukoencephalopathy patient samples increase virus early gene expression and replication rate.

Authors:  Rainer Gosert; Piotr Kardas; Eugene O Major; Hans H Hirsch
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

2.  CpG oligodeoxynucleotides block human immunodeficiency virus type 1 replication in human lymphoid tissue infected ex vivo.

Authors:  Erika Schlaepfer; Annette Audigé; Barbara von Beust; Vania Manolova; Markus Weber; Helene Joller; Martin F Bachmann; Thomas M Kundig; Roberto F Speck
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

3.  Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals--the Swiss HIV Cohort Study.

Authors:  Jan Fehr; Tracy R Glass; Séverine Louvel; François Hamy; Hans H Hirsch; Viktor von Wyl; Jürg Böni; Sabine Yerly; Philippe Bürgisser; Matthias Cavassini; Christoph A Fux; Bernard Hirschel; Pietro Vernazza; Gladys Martinetti; Enos Bernasconi; Huldrych F Günthard; Manuel Battegay; Heiner C Bucher; Thomas Klimkait
Journal:  J Transl Med       Date:  2011-01-21       Impact factor: 5.531

4.  Anti-HIV activity mediated by natural killer and CD8+ cells after toll-like receptor 7/8 triggering.

Authors:  Erika Schlaepfer; Roberto F Speck
Journal:  PLoS One       Date:  2008-04-23       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.